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The nuclear pore complex (NPC) conducts macromolecular
transport to and from the nucleus and provides a kinetic/hydro-
phobic barrier composed of phenylalanine-glycine (FG) repeats.
Nuclear transport is achieved through permeation of this
barrier by transport receptors. The transport receptor CRM1
facilitates export of a large variety of cargoes. Export of the
preribosomal 60 S subunit follows this pathway through the
adaptor protein NMD3. Using RNA interference, we depleted
two FG-containing cytoplasmically oriented NPC complexes,
Nup214-Nup88 andNup358, and investigated CRM1-mediated
export. A dramatic defect in NMD3-mediated export of preri-
bosomes was found in Nup214-Nup88-depleted cells, whereas
only minor export defects were evident in other CRM1 cargoes
or upon depletion of Nup358. We show that the large C-termi-
nal FG domain of Nup214 is not accessible to freely diffusing
molecules from the nucleus, indicating that it does not conduct
60 S preribosomes through the NPC. Consistently, derivatives
of Nup214 lacking the FG-repeat domain rescued the 60 S
export defect. We show that the coiled-coil region of Nup214 is
sufficient for 60 S nuclear export, coinciding with recruitment
ofNup88 to theNPC.Our data indicate thatNup214 plays inde-
pendent roles in NPC function by participating in the kinetic/
hydrophobic barrier through its FG-rich domain and by ena-
bling NPC gating through association with Nup88.
Selective communication between the nucleus and the cyto-
plasm in eukaryotes occurs through nuclear pore complexes
(NPC),5 multiprotein assemblies that transverse the nuclear
envelope (NE) (1–3). Each NPC is composed of 30 proteins,
collectively termed nucleoporins (4), and displays an 8-fold
horizontal rotational symmetry in relation to the NE (5). The
general shape of theNPC is conserved from yeast to humans (4,
6, 7), but individual nucleoporins differ widely in sequence. A
large subset of nucleoporins contains long phenylalanine-gly-
cine dipeptide-containing domains (FG repeats), which are
thought to form a hydrophobic/kinetic meshwork creating a
barrier to most macromolecules while allowing passage of
transport receptor complexes (2, 8). These complexes are
thought to pass the NPC by interacting with FG repeats, thus
permeating theNPCcore (8–11). To achieve nuclear transport,
proteins and RNAs bind transport-competent receptors either
directly or indirectly via adaptor proteins (12).
Directionality of transport through the NPC is determined
by the Ran GTP/GDP gradient, which exists between the
nucleus and the cytoplasm (13–15), and possibly by the pres-
ence of specific high affinity binding sites for transport recep-
tors located at either the nuclear or cytoplasmic faces of the
NPC (16). Although the general NPC architecture is symmet-
ric, the localization of several nucleoporins is restricted to
either the nuclear or the cytoplasmic face of the NPC (3), sup-
porting the idea that nucleocytoplasmic asymmetry might be
established by asymmetric distribution of specific binding sites
at the NPC. Indeed, preferential interactions between several
transport receptors and specific FG-containing nucleoporins
have been described in vitro (3). In contrast, recent studies in
yeast show that receptor-mediated nuclear transport is not
affected when FG repeats of asymmetric nucleoporins are
absent (17, 18), indicating that they are not essential for direc-
tional transport and that the FG-domains of different nucleo-
porinsmay be functionally redundant. Furthermore, imaging of
single molecule translocation through the NPC shows that the
most kinetically important interactions during nuclear translo-
cation take place in the central pore and that these interactions
exhibit the characteristics of unbiased diffusion, indicating that
there is no directionality within the NPC itself (19).
Next to permeation, gating is a second proposed mode of
energy-dependent NPC translocation. Gating involves confor-
mational changes of the NPC to achieve transport (20) and is
supported by conformational states that have been detected
under various conditions (21–24). The role of individual
nucleoporins in this process is unknown.
TheNup214-Nup88 subcomplex is localized to the cytoplas-
mic face of the NPC (25, 26). Nup214 is dispensable for in vitro
NPC assembly and protein import (27), but it is essential in
vertebrate cells, and its depletion causes a strongmRNA export
defect (28). Nup214 contains two central coiled coils known to
interact with Nup88 (25, 29) and a long C-terminal FG repeat
that interacts strongly with the transport factor CRM1 in vitro
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in a RanGTP- and cargo-stimulated fashion (29–31). These
data suggest that Nup214 plays an essential role in CRM1-me-
diated export. However, it remains to be elucidated as to
whether and how NPC asymmetry influences transport pro-
cesses that are initiated on the opposite side of theNPC. Recent
studies proposed that the FG-rich domain of the asymmetric
nuclear Nup153 and cytoplasmic Nup214 can cross the NPC
providing a binding site to transport receptors and escorting
transport complexes through the NPC (32–34).
CRM1 mediates the nuclear export of proteins bearing a
nuclear export signal (NES) by binding cooperatively with
RanGTP (35–38). Thenature ofNES-containing cargoes differs
widely. The large subunit of the ribosome is exported to the
cytoplasm via the CRM1 pathway, assisted by the transport
adaptor NMD3 (39–42).
We have compared the roles of the Nup214-Nup88 and
Nup358 complexes in different CRM1 export pathways. We
show that the CRM1-mediated export of the 60 S ribosomal
subunit is dependent on the Nup214-Nup88 subcomplex,
whereas that of small NES cargoes remains relatively unaf-
fected.We show that the central domain of Nup214 is required
for 60 S export and Nup88 targeting to the NPC, whereas the
FG repeats are dispensable.
EXPERIMENTAL PROCEDURES
Antibodies—Anti-hNup358/RanBP2 antiserum, anti-hNup-
358V, and anti-hNup358F were generously provided by V.
Cordes (Karolinska Institute, Stockholm, Sweden) and A. Gast
and F. Melchior (Max Planck Institute for Biochemistry,
Munich, Germany), respectively. Antibodies to Nup214 (43)
anti-hNup88 (BD Transduction Laboratories), monoclonal
antibody (mAb) 414 (Eurogentec/Babco), and anti-HA
(12CA5) were described previously.
Plasmid Construction—pSUPER-358 (43), pSUPER-214,
Rev-S1-GFP (44), and HA-Nup153 (45) were described previ-
ously. The NLS-eGFP-NES insert containing the SV40 nuclear
localization signal (NLS) and protein kinase A inhibitor NES
was subcloned frompBSSK (46) into the pcDNA3 vector (Strat-
agene) using the HindIII-NotI restriction sites. The NLS-eGFP
insert was amplified by PCR from pBSSK using the forward
primer 5-CCCCTCGAGGTCGACGGTATC-3 and a reverse
primer containing a NotI site, 5-ATATATATAGCGGCCGC-
TTAGTTTCTAGACTTGTACAGCTC-3, and subcloned
into pCDNA3 by digestion with HindIII and NotI. GFP-NMD3
and rpL29-GFP were a kind gift from U. Kutay (40). To create
a RNAi-insensitive Nup214 expressing plasmid, DpnI-medi-
ated site-directed mutagenesis was performed on pBlue-
scriptKS()CAN (47) creating four silent mutations in the tar-
get sequence TCACATCCGCTAGCAACAC. Wild type and
mutated Nup214 coding sequences were subcloned into the
EcoRI sites of pcDNA3 (Stratagene). A DNA oligo, which con-
tained AgeI, SacII, and FseI sites, was cloned into the RNAi-
insensitive Nup214 XcmI sites, located at positions 6157 and
6253 of the open reading frame, leading to the parental con-
struct. The AgeI and FseI sites were used to perform unidirec-
tional deletions using the ExoIII/S1 deletion kit (Fermentas).
To create Nup214-FRB, the FRB domain lacking the HA1 tag
from the plasmid pC4-RHE (regulated heterodimerization
kit, Argent) was PCR-amplified and cloned in-frame into the
parental construct using AgeI and SacII sites. To create
pcDNA3HA-Nup214-(585–832), HA-Nup214-(804–1058),
and HA-Nup214-(585–1058), Nup214 regions were PCR-am-
plified on pBluescriptKS()CAN (47) and cloned into
pcDNA3-HA (48). FKBP lacking the HA1 tag and SV40 NLS
was PCR-amplified from the plasmid pC4EN-F1E (regulated
heterodimerization kit, Argent) to clone into pRev(1.4)-GFP
(49) using BamHI and AgeI sites and into GST-NLS-GFP from
plasmid pEW103 (kind gift of Erik Wiemer, Erasmus Univer-
sity, Rotterdam, The Netherlands) using BsrGI and SacII sites.
All constructs were sequenced for confirmation.
Cell Culture and Transfections—Low passage HeLa and
MCF-7 cells (ATCC CCL-2) were grown in Dulbecco’s modi-
fied Eagle’smedium supplementedwith 10% fetal bovine serum
(Invitrogen) and antibiotics at 37 °C and 5% CO2 in a humidi-
fied incubator. Transfections were performed using electropo-
ration on MCF-7 cells as described previously (50) or FuGENE
6 (Roche Applied Science) on HeLa cells according to the man-
ufacturer’s instructions. For all RNAi assays in HeLa cells,
experiments proceeded for 72 h; the amount of pSUPER plas-
mids transfected was 106 ng/cm2 on 70–80% confluent cells.
pSUPERGFP was a generous gift from Rene Bernards, The
Netherlands Cancer Institute, Amsterdam. For immunofluo-
rescence experiments, NLS-GFP, NLS-GFP-NES, and GFP-
NMD3 were co-transfected at a maximum of 47 ng/cm2, pRev-
NES-GFP as described (43), pRev-S1-GFP at 21.7 ng/cm2,
rpL29-GFP at 1.2 ng/cm2, pRev-FKBP-GFP at 1 ng/cm2, and
GST-NLS-GFP-FKBP at 2.3 ng/cm2. For all rescue experiments
pcDNA3-derived plasmids were co-transfected at 5.3 ng/cm2
except for the heterodimerization assays, where Nup214-FRB
was co-transfected at 7.3 ng/cm2 maximum. For Western blot
analysis, pcDNA3 and pcDNA3-HA-derived plasmids were co-
transfected at 26.5 ng/cm2. The non-immunosupresive rapalog
AP21967 (regulated heterodimerization kit, Argent) was used
at 500 nM for 3 h prior to fixation except for Nup214 overex-
pression, whichwas at 250 nM. Leptomycin Bwas used for 2 h at
a concentration of 100 nM.
Immunofluorescence Staining and Image Analysis—Indirect
immunofluorescence was performed as described previously
(43). Images were recorded with Leica TCS NT2 and SP2 con-
focalmicroscopes and analyzed using ImageJ software. For sub-
cellular distribution studies, a minimum of 100 cells/condition
were scored. The presence of Nup214 at the NE (Fig. 3A,
Nup214 expression) was defined as positive when rim intensi-
ties were 3-fold higher than average cytoplasmic intensities as
determined using Image J software. Nup88NE staining analysis
was performed as described previously (43) on 25 cells/sample.
RESULTS
The Nup214-Nup88 Subcomplex Is Dispensable for Basic
NES-mediated Nuclear export—The strong in vitro interaction
betweenNup214 andCRM1 (29–31), suggests that this nucleo-
porin has an important stimulatory role in NES-mediated
nuclear export (16, 30, 31). To test for this possibility, we
depleted Nup214 by expression of Nup214-specific shRNAs in
human cells and recorded the nucleocytoplasmic localization
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of NES-reporter proteins. To confirm efficient depletion,
Western blot analyses were performed on knocked down cells
lysates. As shown in Fig. 1E, Nup214-shRNA resulted in strong
depletion of Nup214 (lane 1), whereas shRNA directed to
Nup358 (lane 2) orGFP (lane 3) hadno effect. As expected from
previous studies, knockdown of Nup214 caused a strong deple-
tion of Nup88, indicating that the stability of these two nucleo-
porins is co-dependent (43). We first tested a NES-reporter
protein consisting of the NES derived from protein kinase A
inhibitor (51) and fused to GFP. The import activity of this
protein is provided by an SV40 NLS. In control cells, this
reporter protein is excluded from the nuclei, indicating that the
NES is active and prevails over the NLS activity. Nuclear accu-
mulation of this protein was detectable when cells were treated
with the CRM1 inhibitor leptomycin B, indicating that NLS-
GFP-NES is exported via CRM1 pathway (Fig. 1, A3). Energy
depletion of transfected cells by chilling on ice resulted in an
even distribution of the protein between the nucleus and the
cytoplasm, indicating that the reporter protein is small enough
to slowly diffuse through the NPC (data not shown). Surpris-
ingly, depletion of the Nup214-Nup88 subcomplex caused only
a small export defect (Fig. 1, A and C). Nuclear export of the
NES-GFP-NLS reporter in cells depleted of Nup358 was unaf-
fected (Fig. 1, B and C). We have previously shown that deple-
tion of Nup358 causes a small reduction in export of a Rev(1.4)-
GFP-NES reporter protein (43), which is targeted to the
cytoplasm and sensitive to leptomycin B (44, 49). In addition to
an NLS, the Rev(1.4) protein also provides nuclear retention
activity which permits a more stringent assessment of nuclear
export. We repeated the above experiments using this reporter
protein. In this case, depletion of eitherNup358 or theNup214-
Nup88 subcomplex resulted in a moderate reduction of export
efficiency (Fig. 1D). As the Nup214-Nup88 subcomplex is
required for anchoring of Nup358 to the NPC (43), the reduc-
tion of nuclear export by depletion of Nup214-Nup88 may be
largely attributable to co-depletion of Nup358 from the NPC.
We concluded that the Nup214-Nup88 subcomplex does not
have a major role in NES-dependent nuclear export of these
cargoes.
The Nup214-Nup88 Subcomplex Is Required for CRM1-me-
diated 60 S Preribosome Export—Considering the discrepancy
between the strong binding in vitro between CRM1 and Nup214
and the weak effects of Nup214 depletion on NES-mediated
FIGURE 1. Wild type levels of the Nup214-Nup88 subcomplex are not
required for basic NES-mediated nuclear export. Shown is the subcellular
distribution of the NES reporter proteins NLS-GFP-NES (A–C) and Rev(1.4)-
NES-GFP (D) depleted for Nup214-Nup88 (A, C, and D) or Nup358 (B, C, and D)
in HeLa and MCF-7 cells. Cells were immunolabeled with anti-hNup214 (A2
and A4) and anti-hNup358F (B2 and B4) primary antibodies and Texas Red-
labeled secondary antibodies. Scale bars represent 20 m. C and D, quantifi-
cation of the subcellular distribution of NLS-GFP-NES and Rev(1.4)-NES-GFP
on knocked down cells. 100 fluorescent cells/condition were scored for pre-
dominantly nuclear (NucCyt), equal (NucCyt), or predominantly cytoplas-
mic (NucCyt) GFP fluorescence intensity. The mean distribution is shown,
and error bars represent standard errors. E, Western blot of HeLa cells trans-
fected with pS-Nup214 (lane 1), pS-Nup358 (lane 2), and pS-GFP (lane 3). Blots
were probed for Nup358, Nup214, Nup153, and Nup88 using anti-Nup358V,
anti-hNup214, mAb 414, and anti-hNup88, respectively. Note that knock-
down protein levels are an underestimate of true knock-down efficiency
because of incomplete targeting of the cell population by transient transfec-
tion, especially noticeable for Nup358.
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export in vivo,wehypothesized thatNup214mightbe required for
certain classes of CRM1-dependent nuclear export substrates. It
has been shown previously that in vertebrates, the large 60 S pre-
ribosome subunit is exported viaCRM1and the transport adaptor
NMD3 (40, 42).We therefore investigated the role of theNup214-
Nup88 subcomplex in 60 S preribosomal nuclear export by study-
ing the localization of GFP-tagged NMD3 (40).
In control cells, GFP-NMD3 was largely excluded from the
nucleus (Fig. 2, A and C). This cytoplasmic localization of
NMD3 was strictly dependent on its NES (Fig. 2, A and C).
Depletion of the Nup214-Nup88 subcomplex resulted in a
striking nuclear redistribution of GFP-NMD3 (Fig. 2, A and C).
In contrast, Nup358-deficient cells showed no difference from
the control (Fig. 2, B andC). The localization of the NMD3NES
remained unchanged in Nup214-shRNA- or Nup358-shRNA-
expressing cells, indicating that NMD3 nuclear import was not
impaired by depletion of the Nup214-Nup88 subcomplex or
Nup358 (data not shown). To confirm that nuclear accumula-
tion of GFP-NMD3 reflected a 60 S preribosome export defect,
the localization of the preribosomal component rpL29 was
assessed in wild type or Nup214-Nup88-depleted cells. Apart
from the accumulation at the nucleoli, which is also observed in
control cells, depletion of Nup214-Nup88 resulted in a strong
nuclear accumulation of GFP-tagged rpL29 (Fig 2, A, panels 8
and 10, andC). In vitro, certain recombinant versions of NMD3
possess a very high affinity for CRM1 (40), 100-fold higher
than regular NESs. To test whether the export defect due to
depletion ofNup214-Nup88was specific for high affinity NESs,
we determined the nuclear export driven by anNES of a similar
affinity, the supraphysiological S1 NES (44). Depletion of
Nup214-Nup88 did not induce nuclear accumulation of this
reporter protein, indicating that the effects were not related to
high affinity CRM1 binding of NMD3 (Fig. 2C).
The FG-repeat Domain of Nup214 Cannot Access the
Nucleus—It has been proposed recently that the FG-domain of
Nup214 could access the nuclear compartment providing a
binding site for export complexes. This mechanism would
explain how a cytoplasmic localized nucleoporin can mediate
export (33, 34). To examine this possibility (Fig. 3,A1), we have
tested accessibility of the C-terminal domain of Nup214 to the
nuclear compartment in vivo. For this, we used a rapamycin-
dependent heterodimerizer system (52). The small (95 amino
acids) FRB protein, one of the two heterodimerizing compo-
nents, was fused to the C terminus of the RNAi-insensitive
Nup214. The other heterodimerizing component, FKBP, was
fused to either GST-NLS-GFP or the NES-deficient Rev(1.4)-
GFP, two constitutively nuclear proteins that cannot freely dif-
fuse across the NPC. As depicted in Fig. 3A, panels 2 and 3,
rapamycin-dependent dimerization would occur only if the
C-terminal FRB-containing domain of Nup214 could reach the
nuclear compartment.
Expression of Nup214-FRB rescued the effects of shRNA-
induced Nup214-Nup88 depletion in Nup214 expressionFIGURE 2. The Nup214-Nup88 subcomplex is required for CRM1-medi-
ated 60 S preribosome export. A and B, subcellular distribution of GFP-
NMD3 and RpL29-GFP expressing HeLa cells 72 h after co-transfection with
pSUPER control (A, panels 1 and 4, 7 and 9, and B, panels 1 and 2) or shRNA
expression plasmids targeting Nup214 (A, panels 2 and 5, 8 and 10) or Nup358
(B, B4, B5, and B6). Cells were fluorescently labeled with anti-hNup214 (A4, A5,
A6, A9, A10) and anti-hNup358F (B4, B5, and B6) primary antibodies and Texas
Red-labeled secondary antibodies. HeLa cells expressing GFP-NMD3NES rep-
resent maximum nuclear accumulation (A3 and B3). Scale bars, 10 m. C,
quantification of results illustrated in A and B showing percentages of cells
presenting nuclear accumulation (Nuccyt) of GFP-NMD3, GFP-NMD3NES,
and rpL29-GFP as well as those for the supraphysiological NES reporter,
Rev(1.4)-GFP-S1. Error bars represent standard errors. wt, wild type.
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(Fig. 3, B, panels 3 and 4, and C, panels 3 and 4) and NMD3
nuclear export (Fig. 3E). This indicates that the Nup214-FRB
RNAi-insensitive derivative of Nup214 is correctly
expressed, targeted to the NE, and functional. Previous stud-
ies have shown that a fusion pro-
tein consisting of a FRB and Rev
NES is small enough (11.5 kDa)
and capable of diffusing freely
through the NPC, indicating that
the FRB component would not
prevent the capacity of the
Nup214 C terminus to cross the
NPC (53). When Nup214-FRB and
GST-NLS-GFP-FKBP were highly
overexpressed (Fig 3D, panels
1–6), the two proteins colocalized
incytoplasmicdots ina rapamycin-
dependent manner (Fig 3D, panels
2 and 3, 5 and 6,and 8 and 9), pro-
viding a control for rapamycin-in-
duced heterodimerization. Fur-
thermore, small amounts of
cytoplasmic GST-NLS-GFP-FKBP
were sufficient to induce a visible
colocalization with Nup214 (Fig.
3D, panels 1, 4, and 7). However,
no rapamycin-induced het-
erodimerization was detected
when the nuclear reporter pro-
teins were confined to the nucleus,
using either GST-NLS-GFP-FKBP
or Rev(1.4)-GFP-FKBP protein
(Fig 3, B, panels 2, 4, and 6, and C,
2, 4, and 6). These results indicate
that the FG-repeat domain of
Nup214 is not able to access the
nuclear compartment from its
cytoplasmic site.
Nup214 FG Repeats Are Dispen-
sable for 60 S Preribosomal Nuclear
Export—To determine which
region of Nup214 was required for
preribosomal nuclear export, we
designed several deletion con-
structs of Nup214 and expressed
them in Nup214-Nup88-depleted
cells. To ensure expression of the
reintroduced Nup214 proteins, we
designed four silent point muta-
tions in the nucleotide sequence
that is targeted by the Nup214
shRNA. To determine the extent
of rescue that can be obtained in
this setup, we transfected HeLa
cells expressing GFP-NMD3
under normal or Nup214-Nup88-
depleted conditions with plasmids
expressing either RNAi-sensitive
or -insensitive Nup214 (Fig. 4A). In control cells, efficient
nuclear export of NMD3 was found in 84% of the cells, and
86% of the cells showed a clear NE staining of Nup214. These
scores were not significantly altered when wild type or
FIGURE 3. The FG-repeat domain of Nup214 does not access the nucleus. A, schematic representation of a
system to assess the nuclear presence of the FG-repeat domain of Nup214. Nucleoporins Nup214-FRB and
Nup88 are represented as red and orange circles, respectively. The dashed red circle around Nup214 represents
the approximate radius of an unstructured Nup214 FG-repeat domain to access the nucleus. After the addition
of the rapamycin dimerizer (blue ovals in A2), nuclear GFP-FKBP (green circles) would accumulate at the NE only
if the Nup214 C terminus has access to the nucleus (A3). Cytoplasmic GFP-FKBP would accumulate at the NE if
the FG-repeat domain of Nup214 has access to the cytoplasm (A4). N, nucleus; C, cytoplasm. B–D, subcellular
localization of GST-NLS-GFP-FKBP (B and D) or Rev(1.4)-FKBP-GFP (C ) after knockdown of endogenous Nup214
and exogenous expression of Nup214-FRB. Note that in D, panels 1–3, GST-NLS-GFP-FKBP is present in the
nucleus and cytoplasm. Nup214 is detected by anti-hNup214 and Texas Red-labeled secondary antibody.
Rapamycin-derived heterodimerizer (AP21967) was added as indicated. Scale bars, 10 m. E, FRB-tagged
Nup214 is active in promoting 60 S preribosomal export. Rescue of GFP-NMD3 nuclear export in Nup214-
depleted cells by parental (left) or FRB-fused Nup214 proteins. Methods used are as described in the legend for
Fig. 4.
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RNAi-insensitive Nup214 was exogenously expressed. Upon
depletion of Nup214-Nup88, only 23% of the cells showed
efficient nuclear export of GFP-NMD3. Concomitantly, the
presence of Nup214 at the NE was reduced to 28% of cells.
Neither GFP-NMD3 export nor the expression of Nup214
was significantly enhanced when an RNAi-sensitive Nup214
mRNA was overexpressed, indicating that the exogenous
Nup214 transcript was recognized and degraded by the
RNAi machinery. In contrast, when the RNAi-insensitive
version was reintroduced, 46% of the cells were able to
export GFP-NMD3. This coincided with a significant
increase of Nup214 expression (Fig. 4A). These data indi-
cated specific rescue of shRNA-mediated depletion of
Nup214-Nup88 by exogenous Nup214 DNA constructs and
defined the dynamic range of the assay to be roughly from 25
to 50% of wild type.
Wenext testedGFP-NMD3nuclear
export of Nup214-Nup88-depleted
cells that lackedFGrepeats to a varying
extent (Fig. 4B). These derivativeswere
createdbyExoIIIdeletionfromaparen-
tal construct that had a small deletion
fromaminoacidposition2055–2076of
the Nup214 sequence. This parental
construct was able to rescue NMD3
export to levels comparable with the
full-length rescue plasmid. Interest-
ingly,mostFG-repeatdeletionsrescued
to similar levels as the parental
construct. Two constructs encoding
Nup214versions lacking theentireFG-
repeat domain (Nup214-(1637–
2075) and Nup214(1–1143)), which
contains the CRM1 binding site, were
not significantly perturbed in their
capacity to rescue NMD3 export. We
conclude that Nup214, but not its FG-
repeat region, is essential for 60 Spreri-
bosomal export.
Nup214 Central Coiled-coil Do-
mains Are Sufficient for 60 S Preri-
bosomal Nuclear Export—Thus far,
our data have indicated that the
Nup214 FG domain cannot access
the nuclear compartment. In addi-
tion, this region seems dispensable
for 60 S preribosomal export. These
facts suggest that Nup214 does not
interact directly with the 60 S
export complex. To further test this
possibility, we expressed three ver-
sions of the central Nup214 coiled-
coil domains. These domains are
required to mediate interaction
with Nup88 and with the NPC (54,
55). Incorporation of the HA1-
tagged coiled-coil domains into the
NPC was analyzed by immunofluo-
rescence and confocal microscopy imaging in Nup214-de-
pleted HeLa cells. As shown previously (54), although the first
and second Nup214 coiled coils showed no or low NE staining
(Fig. 5A, panels 14 and 15, respectively), the protein containing
both domains was targeted to the NE very efficiently (Fig. 5A,
panel 16). Analogously,Nup88NE stainingwas found as high as
wild type levels only when the construct containing both coiled
coils of Nup214 was expressed (Fig. 5, C and D). Next, we ana-
lyzedNMD3 export by confocalmicroscopy imaging. Although
cells expressing the first or second coiled-coil domains (Fig. 5B)
of Nup214 elicited no or little rescue on NMD3 export assays
(Fig 5A, panels 6 and 7), cells expressing the complete central
domain (residues 585–1058) rescued NMD3 export capacity to
the same extent as the Nup214 RNAi-insensitive construct
(Figs. 4B and 5A, panel 8). Western blot analysis of HeLa cell
extracts expressing shRNAi targeting Nup214 and co-trans-
FIGURE 4. Nup214 FG repeats are dispensable for 60 S preribosomal nuclear export. A, rescue of GFP-
NMD3 nuclear export and Nup214 expression in Nup214-Nup88-depleted HeLa cells by exogenous Nup214.
HeLa cells were transfected with Nup214-shRNA expression plasmids (right) or control plasmids (left) and
co-transfected with RNAi-sensitive or -insensitive versions of a Nup214 expression plasmid as indicated below
the graph. White bars represent the percentage of cells showing cytoplasmic GFP-NMD3 staining greater or
equal to nuclear staining. Black bars represent the percentages of cells showing Nup214 staining at the nuclear
envelope. Error bars represent standard errors. B, rescue of GFP-NMD3 nuclear export in Nup214-Nup88-de-
pleted HeLa cells by Nup214 deletion mutants. Nup214 deletion constructs are represented as horizontal bars.
Dark boxes, indicate central coiled-coil domains; vertical bars, FG repeats; arrow, RNAi target. A black oval
denotes a mutated RNAi target. Amino acid (a.a.) positions of Nup214 are shown at the bottom (asterisk). Bars
graph at the right show the percentage of rescue obtained for each construct relative to the parental deletion
construct (dashed line). Error bars represent standard error.
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fected with HA-Nup153, Nup214-(1637–2075), Nup214-
(585–832), Nup214-(804–1058), or Nup214-(585–1058) (Fig.
5B, lanes 2–6, respectively) showed that endogenous Nup214
levels continued to be significantly reduced, indicating that
their expression did not interfere with Nup214 RNAi.
HA-Nup153 expression also did not rescueNMD3 export (data
not shown). These results indicate thatNup214 function in 60 S
export is mediated by the central domain of Nup214, which
interacts with Nup88.
DISCUSSION
In this study we have assessed the role of the Nup214-Nup88
complex in CRM1-mediated nuclear export. Human CRM1 was
first identifiedas aNup214co-precip-
itating protein that interacted specifi-
callywith theC-terminal FGrepeat of
this nucleoporin (29). In vitro, this
interaction is enhanced by RanGTP
and cargo, suggesting a role in trans-
location through the NPC or disas-
sembly of export complexes (30, 31).
It was therefore surprising that deple-
tion of the Nup214-Nup88 subcom-
plex had little or no effect on CRM1-
dependent nuclear export of simple
export cargoes. In yeast, a relatively
strong in vitro interaction between
Nup159 and Xpo1 exists as well (18),
suggesting that this interaction has an
important evolutionary conserved
function.However, removal of thehigh
affinitydomain inNup159doesnotsig-
nificantly affect nuclear export of an
NES-GFP-NLSreporterprotein (18)or
cell viability. Furthermore, studies in
yeast indicate that a significant fraction
of FG repeats canbe removed from the
NPC before cell viability is compro-
mised(17).Therefore, the invivosignif-
icance of the high affinity CRM1/
Nup214 interaction remainsunknown,
but it may function to attenuate rather
than stimulate CRM1-mediated
nuclear export (46).
In addition to contributing to
the hydrophobic inner core of the
NPC (8), the FG-repeat region of
Nup214 has recently been pro-
posed to move cargo through the
NPC from the nuclear to the cyto-
plasmic face of the NE (33, 34). In
fact, the FG-repeat region of
Nup214 is able to cross the NPC by
itself (56) and is predicted to be
unstructured (57) and long
enough to cross the NPC from a
cytoplasmic anchoring point. In
addition, overexpression of Nup214 results in a presence of
this nucleoporin at both sides of the NPC (58). But, irrespec-
tive of such a system operating, our Nup214 depletion data
indicate that it is not essential for CRM1-mediated nuclear
export in cultured cells. To examine whether the C-terminal
tail of Nup214 reaches the nuclear face of the NPC in vivo, we
provided GFP reporter proteins and the C-terminal tail of
Nup214 with rapamycin-dependent heterodimerizing tags.
Using this system, we only detected NPC localization of the
reporter proteins when they were in the cytoplasm, indicat-
ing that the FG-repeat region of Nup214 accesses the cyto-
plasm but not the nucleoplasm under our in vivo conditions.
We found that the presence of theNup214-Nup88 subcomplex
was required forCRM1-mediated nuclear export of 60 S pre-ribo-
FIGURE 5. Nup214 central coiled-coil domains are sufficient for 60 S preribosomal nuclear export. A,
subcellular distribution of GFP-NMD3 expressing HeLa cells 72 h after co-transfection with pSUPER control
(panels 1 and 9, 5 and 13) or pS-Nup214; and with empty pcDNA (panels 2 and 10) or Nup214 rescue plasmids
expressing Nup214-(1637–2075) (panels 3 and 11), Nup214-(1–1143) (panels 4 and 12), Nup214-(585– 832)
(panels 6 and 14), Nup214-(804 –1058) (panels 7 and 15), and Nup214-(585–1058) (panels 8 and 16). Cells were
fluorescently labeled with anti-hNup214 (panels 9 and 12) and anti-HA 12CA5 (panels 13 and 16) primary
antibodies and Texas Red-labeled secondary antibodies. B, Western blot of HeLa cells transfected with pSUPER
empty (lane 7) or pS-Nup214 (lanes 1– 6). HA-Nup153 (lane 2), Nup214-(1637–2075) (lane 3), Nup214-(585–
832) (lane 4), Nup214-(804 –1058) (lane 5) and Nup214-(585–1058) (lane 6) were co-transfected. Blots were
probed for Nup214 and Nup153 using mAb 414, for Nup214-(1637–2075) using anti-hNup214, and for HA1
using 12CA5. C, Nup214 coiled-coil region is sufficient to target Nup88 to the NPC. This is a graphic represen-
tation of fluorescence levels of endogenous Nup88 as a percentage of the empty pSUPER negative control after
knockdown of Nup214 and co-expression of the indicated plasmids. Representative images are shown in D.
Note that the absence of Nup214 reduces endogenous levels of Nup88 (see also Fig. 1E).
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somal subunits. This indicates that different cargoes served by the
same transport receptor have different nucleoporin requirements,
which complements earlier observations that different nucleopor-
ins serve distinct nucleocytoplasmic transport pathways (59–62).
BecausedepletionofNup214hasnogeneral effect onnuclear pro-
tein import (27) or export (this study), the observed preribosomal
nuclear export defect is likely not a consequence of pleiotropic
effects on general protein transport pathways. Also, 60 S export
was rescued by Nup214 versions that cannot bind Dbp5. Dbp5
interaction with Nup214-Nup159 is required for mRNA export
(63, 64), suggesting that the observed 60 S export defects are not
primarily caused by general inhibition of mRNA export.
The mechanism by which large ribonuclear protein complexes
translocate though theNPC remains largely unknown. The size of
a 60 S preribosomal particle (25 nm) is 100-fold that of a GFP
molecule and close to the upper NPC size limit for a nondeform-
able cargo (65), suggesting that a significant conformational
change of the NPC should occur during its translocation. Recent
analysis using cryoelectron tomography of functional Dyctioste-
liumNPCshas revealeddistinct structural states correlatingwitha
variable central volume that likely represent large cargoes in tran-
sit (24).
In yeast, nuclear export of 40 S and 60 S preribosomes was
reported to require the Nup159p-Nup82p-Nsp1p subcom-
plex (63), which is the proposed yeast homologue of the ver-
tebrate Nup214-Nup88-Nup62 subcomplex (55). Both
Nup214-Nup88-Nup62 and Nup159-Nup82-Nsp1 subcom-
plexes are associated through interactions of coiled-coil
domains (54, 55), and these domains in Nup159p and Nsp1p
are necessary and sufficient for cell viability (66, 67). We find
that in vertebrate cells, the requirement of the Nup214-Nup88
subcomplex for 60 S preribosomal export is dependent on the
central coiled-coil domain that contains the Nup88 and possi-
bly Nup62 interaction domains but is not dependent on its N
terminus nor its large FG-repeat region. Because of the struc-
tural characteristics of the Nup214 central domain and its role
in correctly positioning the cytoplasmic Nup214-Nup88 sub-
complex, it is likely part of the cytoplasmic structures of the
NPC. Furthermore, this region lacks FG repeats, thought to be
essential for CRM1 interaction. Therefore, we consider it
unlikely that a direct interaction between Nup214 and the 60 S
preribosomal export complex is required for 60 S export. We
propose, rather, that the Nup214-Nup88 core domain plays a
structural role in large scale conformational changes required
for 60 S preribosome export, perhaps functioning in a hinge-
like manner. This is consistent with deletion analysis in yeast,
which indicates that only the coiled-coil domain ofNup159, the
closest yeast homologue of Nup214, is required for 40 S preri-
bosomal nuclear export (63). Further evidence that the
Nup214-Nup88 subcomplex may be required for nuclear
export of large cargoes is the strong mRNA export defect of
depletion of Nup214 and Nup88 (28) or their yeast equivalents,
Nup159 and Nup82 (59, 60, 68, 69).
In conclusion, we have shown that the Nup214-Nup88 sub-
complex is required for CRM1-mediated export of a specific
cargo, the 60 S preribosome, in a process independent of strong
CRM1-FG interactions.
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